Skip to main content
. 2022 Feb 23;14(5):1135. doi: 10.3390/cancers14051135
PCa prostate cancer
PSA prostate specific antigen
MS mass spectrometry
AUC area under the curve
MRI magnetic resonance imaging
NMR nuclear magnetic resonance
ELISA enzyme-linked immunosorbent assay
DRE digital rectal examination
HPLC high-performance liquid chromatography
FA formic acid
UV/VIS ultraviolet–visible
HPRP high-pH reversed-phase chromatography
LC–MS liquid chromatography–mass spectrometry
HRM high resolution mass spectrometry
DIA data-independent acquisition
FDR false discovery rate
ROC receiver operating characteristic
HE Hematoxylin–eosin
GS Gleason score
EPV events per predictor variable
PEDF pigment epithelium-derived factor
HPX hemopexin
CD99 cluster of differentiation 99
CANX calnexin precursor
FCER2 Fc fragment Of IgE receptor II
HRNR hornerin
KRT13 keratin 13
CD44 cluster of differentiation 44
RNASE2 ribonuclease A family member 2